ABSTRACT
Background Rotational atherectomy (RA) percutaneous coronary intervention (PCI) may cause transient bradycardia or heart block. Traditionally, some operators use prophylactic transvenous pacing wire (TPW) to avoid haemodynamic complications associated with bradycardia. We sought to establish the frequency of bail-out need for emergency TPW insertion in patients undergoing RA PCI that have received no upfront TPW insertion.
Methods We performed a single-centre retrospective study of all patients undergoing RA PCI between October 2009 and October 2022. Patient characteristics, procedural variables and in-hospital complications were registered.
Results A total of 331 patients who underwent RA procedure were analyzed. No patients underwent prophylactic TPW insertion. The mean age was 73.3±9.1 years, 71.6% (n=237) were male, while nearly half of patients were diabetic (N=47.7%, N=158). The right coronary artery was the most common target for RA PCI (40.8%), followed by left anterior descending (34.1%), left circumflex (14.8%) and left main stem artery (10.3%). Twenty (6%) of patients required intraprocedural atropine therapy. Emergency TPW insertion was needed in one patient (0.3%) only. Eight (2.4%) patients died, however only one was adjudicated as possibly related to RA-induced bradycardia. Five patients (1.5%) had ventricular fibrillation arrest while nine (2.7%) required cardiopulmonary resuscitation. Six (1.8%) procedures were complicated by coronary perforation, two (0.6%) were complicated by tamponade while 17 (5.1%) patients experienced vascular access complications.
Conclusions Bail-out transvenous temporary pacing is very rarely required during RA PCI. A standby temporary pacing strategy is reasonable and may avoid unnecessary TPW complications compared to routine use.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA as this was a retrospective observational trial
Funding Statement
Open Access Fee would be paid by Karl Landsteiner University of Health Sciences
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved the Karl-Landsteiner scientific integrity and ethics commission (ethics commission number 1057/2023).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No data from publically available sources were used.
Abbreviations used
- PCI
- percutaneous coronary intervention
- RA
- rotational atherectomy
- TPW
- temporary pacing wire
- RCA
- right coronary artery
- CX
- circumflex coronary artery
- LAD
- left anterior descending artery
- LM
- left main stem
- DM
- diabetes mellitus
- PAD
- peripheral artery disease
- CKD
- chronic kidney disease
- CPR
- cardiopulmonary resuscitation
- VF
- ventricular fibrillation
